SCHEMBL2964335

SCHEMBL2964335

C=CCN(C)S(=O)(=O)OC(=O)C(C)(C)OC(=O)c1cc(-n2c(=O)cc(C(F)(F)F)n(C)c2=O)ccc1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6427527 0.88
SCHEMBL2964332 0.88 PPARD (0.32)
SCHEMBL2963126 0.86
Butafenacil SCHEMBL29482232 0.85 XPA (0.34)
Butafenacil SCHEMBL39148 0.85 XPA (0.34)
Butafenacil SCHEMBL20521380 0.83 XPA (0.34)
SCHEMBL6553913 0.82 MEN1 (0.35)
SCHEMBL9350533 0.82 CTSB (0.33)
SCHEMBL7953660 0.81 PPARG (0.31)
SCHEMBL6553785 0.81 CYP4F2 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7767624-B2 3-Heterocyclyl substituted benzoic acid derivatives BASF AKTIENGESELLSCHAFT (DE) 2010-08-03 US disclosed
US-20050239655-A1 3-heterocyclyl substituted benzoic acid derivatives BASF AKTIENGESELLSCHAFT (DE) 2005-10-27 US disclosed